Biclofibrate is a fibrate drug classified as a peroxisome proliferator-activated receptor alpha agonist, primarily utilized in the treatment of hyperlipidemia to reduce elevated levels of cholesterol and… Read more
Biclofibrate is a fibrate drug classified as a peroxisome proliferator-activated receptor alpha agonist, primarily utilized in the treatment of hyperlipidemia to reduce elevated levels of cholesterol and triglycerides in the blood. By activating PPARα, the drug facilitates the clearance of triglyceride-rich lipoproteins. This category offers high-quality reference standards for the Biclofibrate active pharmaceutical ingredient, alongside related impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous impurity profiling, method validation, and ongoing quality control. Analysts rely on these characterized standards to ensure accurate identification and quantification of potential degradants and metabolic byproducts during stability studies and routine testing, ensuring compliance with regulatory requirements throughout the drug development lifecycle.